Sign in

CIK 0001297184 · Large accelerated filer

Amphastar Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
330702205
Phone
909-980-9484
Business address
11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
  1. 4 Open-market sale CEO & Chief Scientific Officer sold 48,847 shares at an average $18.93 ($924,750)
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G Stake Amended Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. 4 Open-market sale CEO & Chief Scientific Officer sold 40,886 shares at an average $18.92 ($773,546)
  6. 4 Open-market sale CEO & Chief Scientific Officer sold 41,869 shares at an average $18.69 ($782,343)
  7. 4 Open-market sale CEO & Chief Scientific Officer sold 37,931 shares at an average $18.43 ($698,941)
  8. 4 Open-market sale Director sold 639 shares at $18.26 ($11,669)
  9. SC 13G/A Stake Amended Statement of Ownership
  10. 4 Open-market sale CFO, SVP & Treasurer sold 6,495 shares at $18.67 ($121,237)
  11. 8-K Event Regulation FD disclosure
  12. 4 Open-market sale Director sold 500 shares at $17.87 ($8,936)
  13. 8-K Event Executive or director change · Other events
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. 4 Open-market sale Director sold 500 shares at $19.84 ($9,920)
  17. 4 Open-market sale Director sold 500 shares at $18.89 ($9,446)
  18. 4 Open-market sale Director sold 500 shares at $19.90 ($9,948)
  19. 4 Open-market buy Director bought 1,000 shares at $20.26 ($20,260)
  20. 4 Open-market sale CFO, SVP & Treasurer sold 5,512 shares at $20.36 ($112,223)

Page 24 of 48 · 958 filings